Covered recipient · General Payments record
IRL B GREENWELL
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2019–2024
$30,803.25
- Reported across 70 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,186.21 | 52 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $103.63 | 6 |
| Celgene Corporation | $96.03 | 4 |
| Acerta Pharma LLC | $78.45 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $70.08 | 3 |
| PFIZER INC. | $64.34 | 3 |
| Novocure Inc. | $63.52 | 2 |
| BeiGene USA, Inc. | $54.55 | 2 |
| Merck Sharp & Dohme Corporation | $53.53 | 2 |
| Rigel Pharmaceuticals, Inc. | $48.75 | 2 |
| Adaptive Biotechnologies Corporation | $44.81 | 2 |
| SOBI, INC | $41.42 | 2 |
| ADC Therapeutics America, Inc. | $39.11 | 2 |
| GlaxoSmithKline, LLC. | $37.33 | 2 |
| GENZYME CORPORATION | $36.15 | 1 |
| Stemline Therapeutics Inc. | $34.89 | 1 |
| EISAI INC. | $34.54 | 1 |
| Alexion Pharmaceuticals, Inc. | $34.10 | 2 |
| Blueprint Medicines Corporation | $26.24 | 1 |
| Ipsen Biopharmaceuticals, Inc | $25.73 | 1 |
| Incyte Corporation | $25.64 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $24.78 | 1 |
| Daiichi Sankyo Inc. | $23.95 | 1 |
| Regeneron Healthcare Solutions, Inc. | $22.71 | 1 |
| Pharmacosmos Therapeutics Inc. | $22.46 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.23 | 1 |
| JAZZ PHARMACEUTICALS INC. | $19.36 | 1 |
| Janssen Biotech, Inc. | $19.28 | 1 |
| SERVIER PHARMACEUTICALS LLC | $18.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (52)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.